- Home
- MRNA vs NTAP Comparison
MRNA vs NTAP Comparison
Compare MRNA & NTAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- NTAP
- Stock Information
- Founded
- MRNA 2010
- NTAP 1992
- Country
- MRNA United States
- NTAP United States
- Employees
- MRNA N/A
- NTAP N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- NTAP Electronic Components
- Sector
- MRNA Health Care
- NTAP Technology
- Exchange
- MRNA Nasdaq
- NTAP Nasdaq
- Market Cap
- MRNA 16.0B
- NTAP 17.1B
- IPO Year
- MRNA 2018
- NTAP 1995
- Fundamental
- Price
- MRNA $24.72
- NTAP $82.61
- Analyst Decision
- MRNA Hold
- NTAP Buy
- Analyst Count
- MRNA 20
- NTAP 17
- Target Price
- MRNA $54.47
- NTAP $127.88
- AVG Volume (30 Days)
- MRNA 10.2M
- NTAP 2.8M
- Earning Date
- MRNA 05-01-2025
- NTAP 05-29-2025
- Dividend Yield
- MRNA N/A
- NTAP 2.53%
- EPS Growth
- MRNA N/A
- NTAP 23.16
- EPS
- MRNA N/A
- NTAP 5.40
- Revenue
- MRNA $3,236,000,000.00
- NTAP $6,508,000,000.00
- Revenue This Year
- MRNA N/A
- NTAP $6.83
- Revenue Next Year
- MRNA $22.07
- NTAP $4.78
- P/E Ratio
- MRNA N/A
- NTAP $15.30
- Revenue Growth
- MRNA N/A
- NTAP 5.29
- 52 Week Low
- MRNA $23.15
- NTAP $71.84
- 52 Week High
- MRNA $170.47
- NTAP $135.45
- Technical
- Relative Strength Index (RSI)
- MRNA 36.68
- NTAP 40.57
- Support Level
- MRNA $23.68
- NTAP $80.22
- Resistance Level
- MRNA $27.21
- NTAP $85.13
- Average True Range (ATR)
- MRNA 2.06
- NTAP 4.18
- MACD
- MRNA -0.03
- NTAP 0.73
- Stochastic Oscillator
- MRNA 26.98
- NTAP 55.57
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About NTAP NetApp Inc.
NetApp Inc is a provider of enterprise data management and storage solutions. The company's segments include Hybrid Cloud and Public Cloud. It generates maximum revenue from the Hybrid Cloud segment. The Hybrid Cloud segment offers a portfolio of storage management and infrastructure solutions that help customers recast their traditional data centers with the power of cloud. This portfolio is designed to operate with public clouds to unlock the potential of hybrid, multi-cloud operations. Hybrid Cloud is composed of software, hardware, and related support, as well as professional and other services.